Literature DB >> 694773

Investigation of the effect of hydroxyurea on the cell cycle and the development of necrosis in the embryonic CNS of mice.

R Herken, H J Merker, R Krowke.   

Abstract

On day 10 of gestation pregnant mice (strain NMRI) were given an intravenous injection of 500 mg/kg Hydroxyurea (HU). Simultaneously either 5 muCi/g or 10 muCi/g 3H-thymidine (3H-Tdr; specific activity 5Ci/mmol) was administered to the animals. At various times after treatment embryos and electron microscopy. Two hours after administration of HU condensations of the chromatin structure could be detected electron microscopically in some cells. Thirty minutes later the nucleolus became smaller and denser, the cytoplasm shrank, and the cell organelles moved closer together. Three hours after application of the drug break-down of the involved cells set in. As in the autoradiograms about 98% of the counted necroses were labelled, and since labelled thymidine is almost exclusively incorporated during the S-phase, it can be stated the HU influences only metabolic processes which take place during the S-phase. From the morphological findings it can be concluded that in the case of the S-phase-specific metabolic pathway, which is influenced by HU, we are primarily dealing with DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 694773     DOI: 10.1002/tera.1420180113

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  3 in total

1.  Initial development of capillaries in the neuroepithelium of the mouse.

Authors:  R Herken; W Götz; K H Wattjes
Journal:  J Anat       Date:  1989-06       Impact factor: 2.610

2.  Effects of hydroxyurea on postnatal growth and behaviour of rats.

Authors:  H Fritz; R Hess
Journal:  Agents Actions       Date:  1980-09

3.  Shoutai pills improve the quality of oocytes exposed to the chemotherapeutic drug Hydroxyurea.

Authors:  Yuwei Zhang; Ruizhi Tan; Li Wang; Xiaoyan Shi; Yu Li; Xia Zhong; Xiaoxia He; Bo Xiong
Journal:  Aging (Albany NY)       Date:  2020-05-10       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.